Michael V Cohen

6PUBLICATIONS
1CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeuticsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2024
Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 Assembly.

Michael V Cohen, James M Downey

|Feb 25, 2023
Lethal Caspase-1/4-Dependent Injury Occurs in the First Minutes of Coronary Reperfusion and Requires Calpain Activity.

Xi-Ming Yang, Michael V Cohen, Sarah Sayner

|Jul 15, 2021
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart.

Sergey V Popov, Leonid N Maslov, Natalia V Naryzhnaya

|Oct 25, 2019
What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?

Michael V Cohen, James M Downey

|Feb 13, 2019
Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.

Xi-Ming Yang, Sushee Gadde, Jonathon P Audia

Pageof 1

Frequent Collaborators

1 joint publications

Leonid N Maslov